All In Biotech

Drug Trial Radar · NCT05194306

PERTRIAL - Perla® Preservation Solution

Evaluation of the Safety and Performance of Perla® Preservation Solution for Donor Liver and Kidney for Transplantation

Last checked: Nov 20, 2026Latest source record: May 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

11

Actual

Start

Dec 11, 2021

Primary completion

Apr 30, 2022

Study completion Apr 30, 2022

Sponsor

Lead sponsor
Advanced Life SolutionsIndustry
Sponsor type
Industry
Collaborators
Complexo Hospitalario Universitario de A Coruña
First posted
Jan 18, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Perla® is a Cold Preservation Solution, with purpose to wash out, preserve during transport liver and kidney grafts in optimal conditions from the donor to the recipient. The purpose of the PERTRIAL clinical investigation is to demonstrate the Performance and Safety of Perla® Cold Preservation solution.

Conditions

  • Organ Transplant
  • Ischemic Reperfusion Injury

Interventions

  • Perla® Cold Preservation solutionDrug

    Perla® must be cooled to 2° to 6 °C prior to use. The cold Preservation Solution is used to flush the isolated organ immediately before removal from the donor and/or immediately after removal from the donor. The solution is then left in the organ vasculature during hypothermic storage and transportation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Graft Function Rate (Kidney & Liver)Time frame: 7 days post transplant

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centro Hospitalario Universitario A Coruña (CHUAC)

    A Coruña, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.